… rejected a bill to reform our health care and insurance systems. This was the last of three proposals the Senate … members on both sides of the aisle to create a health care system that meets the needs of people with Parkinson's and …

… pharmaceutical company solely devoted to central nervous system (brain and spinal cord) disorders. …

… movements. The general objective of the proposal is to demonstrate that Nur77 and RXR can be targeted to reduce … both heterodimer partners (Nur77/RXR as a transcriptional complex) are necessary, we will investigate the effect of … models (gene rescue), using a virally driven gene delivery system, exacerbated dyskinesia. This transcription …

… Nmnat1 Gene Therapy for Parkinson's Disease Promising Outcomes of Original Grant: In the previous application, we tested the hypothesis that gene delivery of NMNAT-1 would protect striatal innervation in … Neurodegeneration … Academia/Nonprofit …

… will test the toxicity of these mutants in an experimental system by investigating dopaminergic loss in the substantia … The dual approach (in vitro characterization in a cell free system and the in vivo approach) will allow us to correlate … we tested the toxicity of these mutants in an experimental system by investigating dopaminergic loss in the substantia …

… Project Description:  The study aims to develop a Web-based system to monitor subjects in their homes with miniature … measure the severity of Parkinson’s symptoms. The Web-based system will provide videoconferencing capability, access to … Outcome: The project will provide the first Web-based system to remotely access sensor data recorded from …